Pasireotide LAR Administration in Lymphocele Prevention After Axillary Node Dissection for Breast Cancer
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Cancer
Interventions: DRUG: PASIREOTIDE|DRUG: PLACEBO
Sponsor: Alliance Pour La Recherche en Cancerologie